Literature DB >> 31344458

A metabolomics-guided approach to discover Fusarium graminearum metabolites after removal of a repressive histone modification.

Donovon A Adpressa1, Lanelle R Connolly2, Zachary M Konkel1, George F Neuhaus1, Xiao L Chang2, Brett R Pierce2, Kristina M Smith3, Michael Freitag4, Sandra Loesgen5.   

Abstract

Many secondary metabolites are produced by biosynthetic gene clusters (BGCs) that are repressed during standard growth conditions, which complicates the discovery of novel bioactive compounds. In the genus Fusarium, many BGCs reside in chromatin enriched for trimethylated histone 3 lysine 27 (H3K27me3), a modification correlated with transcriptional gene silencing. Here we report on our progress in assigning metabolites to genes by using a strain lacking the H3K27 methyltransferase, Kmt6. To guide isolation efforts, we coupled genetics to multivariate analysis of liquid chromatography-mass spectrometry (LCMS) data from both wild type and kmt6, which allowed identification of compounds previously unknown from F. graminearum. We found low molecular weight, amino acid-derived metabolites (N-ethyl anthranilic acid, N-phenethylacetamide, N-acetyltryptamine). We identified one new compound, protofusarin, as derived from fusarin biosynthesis. Similarly, we isolated large amounts of fusaristatin A, gibepyrone A, and fusarpyrones A and B, simply by using the kmt6 mutant, instead of having to optimize growth media. To increase the abundance of metabolites underrepresented in wild type, we generated kmt6 fus1 double mutants and discovered tricinolone and tricinolonoic acid, two new sesquiterpenes belonging to the tricindiol class. Our approach allows rapid visualization and analyses of the genetically induced changes in metabolite production, and discovery of new molecules by a combination of chemical and genetic dereplication. Of 22 fungal metabolites identified here, 10 compounds had not been reported from F. graminearum before. We show that activating silent metabolic pathways by mutation of a repressive chromatin modification enzyme can result in the discovery of new chemistry even in a well-studied organism, and helps to connect new or known small molecules to the BGCs responsible for their production.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fungi; H3K27; Histone methyltransferase; Metabolomics; Secondary metabolites

Mesh:

Substances:

Year:  2019        PMID: 31344458     DOI: 10.1016/j.fgb.2019.103256

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  5 in total

1.  Metabolomics-guided analysis reveals a two-step epimerization of deoxynivalenol catalyzed by the bacterial consortium IFSN-C1.

Authors:  Gang Wang; Yanxia Wang; Huizi Man; Yin-Won Lee; Jianrong Shi; Jianhong Xu
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-21       Impact factor: 4.813

Review 2.  Polycomb Repression without Bristles: Facultative Heterochromatin and Genome Stability in Fungi.

Authors:  John B Ridenour; Mareike Möller; Michael Freitag
Journal:  Genes (Basel)       Date:  2020-06-09       Impact factor: 4.096

Review 3.  Secondary Metabolite Gene Regulation in Mycotoxigenic Fusarium Species: A Focus on Chromatin.

Authors:  Anna Katharina Atanasoff-Kardjalieff; Lena Studt
Journal:  Toxins (Basel)       Date:  2022-01-25       Impact factor: 4.546

4.  Comparative Genomics of Eight Fusarium graminearum Strains with Contrasting Aggressiveness Reveals an Expanded Open Pangenome and Extended Effector Content Signatures.

Authors:  Tarek Alouane; Hélène Rimbert; Jörg Bormann; Gisela A González-Montiel; Sandra Loesgen; Wilhelm Schäfer; Michael Freitag; Thierry Langin; Ludovic Bonhomme
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

5.  Transcription Factor Repurposing Offers Insights into Evolution of Biosynthetic Gene Cluster Regulation.

Authors:  Wenjie Wang; Milton Drott; Claudio Greco; Dianiris Luciano-Rosario; Pinmei Wang; Nancy P Keller
Journal:  mBio       Date:  2021-07-20       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.